Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy

Next Previous
Trial Profile

Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Oct 2018

At a glance

  • Drugs Denosumab (Primary)
  • Indications Peripheral neuropathies; Rheumatic disorders
  • Focus Adverse reactions

    • Most Recent Events

    • 03 Oct 2018 Planned End Date changed from 16 May 2020 to 6 Mar 2019.
    • 03 Oct 2018 Status changed from recruiting to active, no longer recruiting.
    • 06 Jun 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top